PBE | Invesco Dynamic Biotechnology & Genome ETF Overview

(Stock Exchange: AMEX)

Day's Range	67.96 - 68.81
52 Week Range	56.21 - 72.84
Beta	0.78
Implied Volatility	18.90%
IV Rank	64.61%
Day's Volume	7,187
Average Volume	6,615
Shares Outstanding	4,550,000
Inception Date	2005-06-23

Assets	262,108,800
Asset Class	Equity
Expense Ratio	0.59
P/E Ratio	18.23
EPS	3.77
Dividend Yield	0.05%
Dividend Per Share	0.03
Dividend ExDate	N/A
Dividend PayDate	N/A

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

*Chart delayed

Watching at PBE technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on PBE Technicals page.